Latest News

Deucravacitinib for Psoriasis Effective by Week 1, Sustained Over 52 Weeks
Deucravacitinib for Psoriasis Effective by Week 1, Sustained Over 52 Weeks

July 16th 2024

In this analysis, investigators highlighted the results of treating psoriasis with deucravacitinib in the phase 3 POETYK PSO-1 and PSO-2 trials.

GLP-1RAs Not Linked to Increased Risk for Suicidal Thoughts
GLP-1RAs Not Linked to Increased Risk for Suicidal Thoughts

July 16th 2024

David Levinthal, MD, PhD | Credit: University of Pittsburgh
Cyclic Vomiting Syndrome Clinical Practice Update Guides Diagnosis, Management

July 16th 2024

Socioeconomic Factors Linked to Persistently Active Rheumatoid Arthritis
Socioeconomic Factors Linked to Persistently Active Rheumatoid Arthritis

July 16th 2024

Study Highlights Risk of PsA Among Psoriasis Patients with Type 2 Diabetes Mellitus
Study Highlights Risk of PsA Among Psoriasis Patients with Type 2 Diabetes Mellitus

July 15th 2024

Lungcast
Don’t Miss a Beat
Diabetes Dialogue
New Insight with Dr. Veeral Sheth
Crisis Point

Conference Coverage

View All
JAK Inhibitor Updates: Upadacitinib and the Level-Up Trial
JAK Inhibitor Updates: Upadacitinib and the Level-Up Trial

July 5th 2024

HCPLive Five at ADA 2024 | Image Credit: HCPLive
HCPLive Five at ADA 2024

July 3rd 2024

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

July 3rd 2024

Carol Levy, MD | Credit: T1D Exchange
Diabetes Dialogue: Patient Considerations for Inhaled Insulin, with Carol Levy, MD

June 30th 2024

Video Series
Video Interviews
Podcasts
John Buse, MD, PhD | Credit: UNC School of Medicine
HCPLive Endocrinology Month In Review June 2024 Thumbnail
New Insight with Veeral Sheth, MD Podcast logo | Image Credit: HCPLive
Carol Levy, MD | Credit: T1D Exchange
Monica Gomberg, MD | Credit: Blue Circle Health
Davida Kruger, NP | Credit: Henry Ford Health System
Stopping Lung Cancer Before It Starts with Steven Dubinett, MD, and Avrum Spira, MD
Anastasia Albanese-O'Neill, PhD, APRN | Credit: LinkedIn

All News

© 2024 MJH Life Sciences

All rights reserved.